Cutler Group LP Ac Immune Sa Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$4.47 - $5.58 $4,470 - $5,580	-1,000 Reduced 47.62%	1,100 $5,000
Q3 2020 Oct 27, 2020	BUY	$4.78 - $9.06 $9,082 - $17,214	1,900 Added 950.0%	2,100 $10,000
Q2 2020 Jul 22, 2020	BUY	$6.57 - $8.3 $657 - $830	100 Added 100.0%	200 $1,000
Q1 2020 May 07, 2020	BUY	$4.24 - $9.89 $424 - $989	100 New	100 $0

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $233M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.